← Leaderboards
Yasmin L Hurd
Icahn School Of Medicine At Mount Sinai
$58,238,356
Attributed
$61,449,091
Total exposure
22
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.5M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$61,449,091 · 21
VA$0 · 1
By mechanism
R01$32,751,296 · 10
UH3$10,316,590 · 1
UG3$7,484,180 · 1
T32$5,648,972 · 1
P01$2,945,594 · 3
R21$914,991 · 2
Top collaborators
- Stella Dracheva5 shared
- An-Li Wang3 shared
- Robert D. Blitzer2 shared
- Hirofumi Morishita2 shared
- Jacqueline-Marie Ferland1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Eric J Nestler$73,310,132
- Randall Jordan Ellis$78,336
- Jacqueline-Marie Ferland$996,065
- Marta Filizola$11,220,258
- Kion Winston$49,538
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsBehaviorMolecularBrainAddictionHeroinPharmaceutical PreparationsInsightRattusLinkAnimal ModelSelf AdministrationNeurobiologyBehavioralGene ExpressionGenesEpigenetic ProcessMediatingNucleus AccumbensRegulationCorpus Striatum StructureBrain RegionOpioidCannabis
Grant awards (116)
Molecular underpinnings of the developmental Effects of Cannabis$838,504
R01 · FY2025 · DA · contact PI
Molecular Neurobiology of Human Opioid Use Disorder$586,397
R01 · FY2025 · DA · contact PI
Impact of juvenile social isolation on maturation of frontal circuit and SUD-relevant behavior$391,925
R34 · FY2025 · DA
Transcriptional Regulation In Human Opioid Use Disorders$281,387
P01 · FY2025 · DA · contact PI
Cannabidiol in the treatment of opioid use disorder$10,316,590
UH3 · FY2024 · DA · contact PI
Molecular underpinnings of the developmental Effects of Cannabis$843,067
R01 · FY2024 · DA · contact PI
Molecular Neurobiology of Human Opioid Use Disorder$638,529
R01 · FY2024 · DA · contact PI
Impact of juvenile social isolation on maturation of frontal circuit and SUD-relevant behavior$391,833
R34 · FY2024 · DA
Transcriptional Regulation In Human Opioid Use Disorders$240,463
P01 · FY2024 · DA · contact PI
Regulation of Gene Enhancers in Human Heroin Use$32,925
P01 · FY2024 · DA · contact PI
Molecular underpinnings of the developmental Effects of Cannabis$842,905
R01 · FY2023 · DA · contact PI
Translating CBD Treatment for Heroin Addiction$795,918
R01 · FY2023 · DA · contact PI
Molecular Neurobiology of Human Opioid Use Disorder$542,193
R01 · FY2023 · DA · contact PI
Regulation of Gene Enhancers in Human Heroin Use$266,963
P01 · FY2023 · DA · contact PI
Molecular underpinnings of the developmental Effects of Cannabis$851,045
R01 · FY2022 · DA · contact PI
Translating CBD Treatment for Heroin Addiction$775,802
R01 · FY2022 · DA · contact PI
Molecular Neurobiology of Human Opioid Use Disorder$546,249
R01 · FY2022 · DA · contact PI
Regulation of Gene Enhancers in Human Heroin Use$266,963
P01 · FY2022 · DA · contact PI
Translating CBD Treatment for Heroin Addiction$778,144
R01 · FY2021 · DA · contact PI
Molecular Neurobiology of Human Opioid Use Disorder$605,591
R01 · FY2021 · DA · contact PI
Cell Specificity of the Human Heroin Epigenome$538,249
R01 · FY2021 · DA
Regulation of Gene Enhancers in Human Heroin Use$240,940
P01 · FY2021 · DA · contact PI
Translating CBD Treatment for Heroin Addiction$778,290
R01 · FY2020 · DA · contact PI
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation$656,003
R01 · FY2020 · DA · contact PI
Cell Specificity of the Human Heroin Epigenome$538,249
R01 · FY2020 · DA
Regulation of Gene Enhancers in Human Heroin Use$266,961
P01 · FY2020 · DA · contact PI
Cannabidiol in the treatment of opioid use disorder$7,484,180
UG3 · FY2019 · DA · contact PI
Translating CBD Treatment for Heroin Addiction$797,404
R01 · FY2019 · DA · contact PI
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation$656,003
R01 · FY2019 · DA · contact PI
Molecular Neurobiology of Human Drug Abuse$563,709
R56 · FY2019 · DA · contact PI
Cell Specificity of the Human Heroin Epigenome$538,249
R01 · FY2019 · DA
Regulation of Gene Enhancers in Human Heroin Use$261,027
P01 · FY2019 · DA · contact PI
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation$584,165
R01 · FY2018 · DA · contact PI
Cell Specificity of the Human Heroin Epigenome$538,249
R01 · FY2018 · DA
Molecular Neurobiology of Human Drug Abuse$509,398
R01 · FY2018 · DA · contact PI
Transcriptional and Epigenetic Mechanisms in Human Heroin Abuse$228,827
P01 · FY2018 · DA · contact PI
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation$9,051
R01 · FY2018 · DA · contact PI
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation$614,728
R01 · FY2017 · DA · contact PI
Cell Specificity of the Human Heroin Epigenome$540,499
R01 · FY2017 · DA
Molecular Neurobiology of Human Drug Abuse$520,448
R01 · FY2017 · DA · contact PI
Transcriptional and Epigenetic Mechanisms in Human Heroin Abuse$193,382
P01 · FY2017 · DA · contact PI
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation$110,175
R01 · FY2017 · DA · contact PI
Cannabinoid Function in the CNS: From Molecules to Disease Mechanisms$20,000
R13 · FY2017 · DA · contact PI
Molecular Neurobiology of Human Drug Abuse$5,767
R01 · FY2017 · DA · contact PI
Molecular Neurobiology of Human Drug Abuse$638,358
R01 · FY2016 · DA · contact PI
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation$611,891
R01 · FY2016 · DA · contact PI
Multigenerational Epigenetic Effects of Cannabis Exposure$496,464
R01 · FY2016 · DA · contact PI
Transcriptional and Epigenetic Mechanisms in Human Heroin Abuse$225,283
P01 · FY2016 · DA · contact PI
Molecular Neurobiology of Human Drug Abuse$8,467
R01 · FY2016 · DA · contact PI
Cannabinoid Function in the CNS: From Molecules to Disease Mechanisms$1
R13 · FY2016 · DA · contact PI
Molecular Neurobiology of Human Drug Abuse$630,139
R01 · FY2015 · DA · contact PI
Multigenerational Epigenetic Effects of Cannabis Exposure$468,924
R01 · FY2015 · DA · contact PI
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation$387,503
R01 · FY2015 · DA · contact PI
Transcriptional and Epigenetic Mechanisms in Human Heroin Abuse$211,646
P01 · FY2015 · DA · contact PI
Cannabinoid Function in the CNS: From Molecules to Disease Mechanisms$20,000
R13 · FY2015 · DA · contact PI
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation$4,790
R01 · FY2015 · DA · contact PI
Molecular Neurobiology of Human Drug Abuse$654,851
R01 · FY2014 · DA · contact PI
Multigenerational Epigenetic Effects of Cannabis Exposure$445,208
R01 · FY2014 · DA · contact PI
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation$409,073
R01 · FY2014 · DA · contact PI
Transcriptional and Epigenetic Mechanisms in Human Heroin Abuse$228,827
P01 · FY2014 · DA · contact PI
Mount Sinai Medical Scientist Training Program$50,134
T32 · FY2014 · GM · contact PI
Mount Sinai Medical Scientist Training Program$50,134
T32 · FY2014 · GM · contact PI
Mount Sinai Medical Scientist Training Program$993,091
T32 · FY2013 · GM · contact PI
The Opioid mesolimbic system in heroin abuse$455,810
R01 · FY2013 · DA · contact PI
Multigenerational Epigenetic Effects of Cannabis Exposure$433,555
R01 · FY2013 · DA · contact PI
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation$413,292
R01 · FY2013 · DA · contact PI
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation$155,309
R01 · FY2013 · DA · contact PI
Mount Sinai Medical Scientist Training Program$99,310
T32 · FY2013 · GM · contact PI
Development of Novel Medication Strategies for Opiate Abuse$0
I01 · FY2013 · VA · contact PI
Mount Sinai Medical Scientist Training Program$1,042,746
T32 · FY2012 · GM · contact PI
The Opioid mesolimbic system in heroin abuse$475,132
R01 · FY2012 · DA · contact PI
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation$452,559
R01 · FY2012 · DA · contact PI
Multigenerational Epigenetic Effects of Cannabis Exposure$426,244
R01 · FY2012 · DA · contact PI
The neuronal basis of cannabis-induced developmental deficits in the CNS$309,440
R01 · FY2012 · DA · contact PI
Mount Sinai Medical Scientist Training Program$148,965
T32 · FY2012 · GM · contact PI
The Opioid mesolimbic system in heroin abuse$46,451
R01 · FY2012 · DA · contact PI
Development of Novel Medication Strategies for Opiate Abuse$0
I01 · FY2012 · VA · contact PI
MOUNT SINAI MEDICAL SCIENTIST TRAINING PROGRAM$977,733
T32 · FY2011 · GM · contact PI
The Opioid mesolimbic system in heroin abuse$475,417
R01 · FY2011 · DA · contact PI
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation$438,432
R01 · FY2011 · DA · contact PI
The neuronal basis of cannabis-induced developmental deficits in the CNS$309,440
R01 · FY2011 · DA · contact PI
Reversing Cocaine-Induced Plasticity with GSK3 Inhibitors$205,519
R21 · FY2011 · DA
MOUNT SINAI MEDICAL SCIENTIST TRAINING PROGRAM$196,680
T32 · FY2011 · GM · contact PI
Cannabidiol as Treatment Intervention for Opiate Relapse$123,311
R21 · FY2011 · DA · contact PI
Development of Novel Medication Strategies for Opiate Abuse$0
I01 · FY2011 · VA · contact PI
MOUNT SINAI MEDICAL SCIENTIST TRAINING PROGRAM$1,071,761
T32 · FY2010 · GM · contact PI
The Opioid mesolimbic system in heroin abuse$475,842
R01 · FY2010 · DA · contact PI
Cannabidiol as Treatment Intervention for Opiate Relapse$331,911
R21 · FY2010 · DA · contact PI
The neuronal basis of cannabis-induced developmental deficits in the CNS$319,011
R01 · FY2010 · DA · contact PI
Reversing Cocaine-Induced Plasticity with GSK3 Inhibitors$254,250
R21 · FY2010 · DA
MOUNT SINAI MEDICAL SCIENTIST TRAINING PROGRAM$1,018,418
T32 · FY2009 · GM · contact PI
The Opioid mesolimbic system in heroin abuse$573,487
R01 · FY2009 · DA · contact PI
The neuronal basis of cannabis-induced developmental deficits in the CNS$322,233
R01 · FY2009 · DA · contact PI
The neuronal basis of cannabis-induced developmental deficits in the CNS$334,208
R01 · FY2008 · DA · contact PI
Neurodevelopmental Effects of Adolescent Cannabis Use$275,629
R01 · FY2008 · DA · contact PI
Effects of Drug Abuse on Human Neurodevelopment$401,791
R01 · FY2007 · DA · contact PI
Dynorphin /kappa mesolimbic system in heroin abuse$350,527
R01 · FY2007 · DA · contact PI
Neurodevelopmental Effects of Adolescent Cannabis Use$281,255
R01 · FY2007 · DA · contact PI
Dynorphin /kappa mesolimbic system in heroin abuse$442,849
R01 · FY2006 · DA · contact PI
Effects of Drug Abuse on Human Neurodevelopment$413,792
R01 · FY2006 · DA · contact PI
Neurodevelopmental Effects of Adolescent Cannabis Use$289,655
R01 · FY2006 · DA · contact PI
Dynorphin /kappa mesolimbic system in heroin abuse$251,793
R01 · FY2005 · DA
Effects of Drug Abuse on Human Neurodevelopment$202,500
R01 · FY2005 · DA
Neurodevelopmental Effects of Adolescent Cannabis Use$81,000
R01 · FY2005 · DA
Neurodevelopmental Effects of Adolescent Cannabis Use$81,000
R01 · FY2005 · DA
Effects of Drug Abuse on Human Neurodevelopment$67,500
R01 · FY2005 · DA
Effects of Drug Abuse on Human Neurodevelopment$270,000
R01 · FY2004 · DA
Dynorphin /kappa mesolimbic system in heroin abuse$264,969
R01 · FY2004 · DA
Neurodevelopmental Effects of Adolescent Cannabis Use$162,000
R01 · FY2004 · DA
Effects of Drug Abuse on Human Neurodevelopment$67,500
R01 · FY2004 · DA
Dynorphin /kappa mesolimbic system in heroin abuse$66,690
R01 · FY2004 · DA
Effects of Drug Abuse on Human Neurodevelopment$270,000
R01 · FY2003 · DA
Dynorphin /kappa mesolimbic system in heroin abuse$266,202
R01 · FY2002 · DA
MOLECULAR EFFECT OF DRUG ABUSE ON HUMAN NEURODEVELOPMENT$135,112
R01 · FY2001 · DA
MOLECULAR EFFECT OF DRUG ABUSE ON HUMAN NEURODEVELOPMENT$299,331
R01 · FY2000 · DA
MOLECULAR EFFECT OF DRUG ABUSE ON HUMAN NEURODEVELOPMENT$59,400
R01 · FY2000 · DA